International Publisher of Science, Technology and Medicine

Journal of Pharmaceutics & Drug Delivery Research

Editorial Board

Bo Michniak-Kohn

Editorial Board Members:

Bo Michniak-Kohn, PhD
Director
Center for Dermal Research (CDR) & Laboratory for Drug Delivery (LDD)
Rutgers University, USA

Biography :

Dr. Bo Michniak-Kohn is Academically appointed as Professor of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey.

 Biography
Research Interest :
  • Optimization of topical, transdermal and buccal drug delivery.
  • Development of novel permeation models and computational modeling.
  • Design and evaluation of novel dermal penetration enhancers and retardants & their structure-activity relationships.
  • Design and testing of novel formulations for topical and transdermal drug delivery including creams, emulsions, gels and micro-and nano-carrier systems.
  • Treatment & therapeutics for dermatological diseases such as atopic dermatitis, melanoma and psoriasis.
  • Physical approaches to enhancing dermal drug delivery: iontophoresis, microneedles as well as formulation optimization.
  • Visualization of drug transport pathways in skin using Raman, Fourier Transform Infra-Red spectroscopy, electron and confocal microscopy.
  • Development of novel human tissue cultured skin equivalents for permeability testing.
  • Computational approaches to predicting skin transport of drugs.
  • Optimization of buccal drug delivery.
  •  Pharmacokinetics and ADME studies in animals and humans.
 Research Interest
Hirofumi Takeuchi

Hirofumi Takeuchi, PhD
Dean of Graduate School
Chair of International Affairs
Gifu Pharmaceutical University, Japan

Biography :

Dr. Hirofumi Takeuchi is professor of department of pharmaceutical technology, Gifu Pharmaceutical University. e received his B.S. (1979), M.S. (1981) and Ph.D (1984) in pharmaceutical sciences from Kyoto University. He joined Gifu Pharmaceutical University GPUas a faculty member in 1984, and became Lecture in 1988. He is now Professor of GPU and the dean of graduate school of GPU. He spent  one year as a visiting scientist at Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, in 1989-1990. e is now working for several scientific societies such as for the vice president of The Society of Powder Technology, Japan, and CRS (Controlled Release Society) Board of Scientific Advisors and so on.

 Biography
Research Interest :

His research interest includes Modified Drug delivery & Drug release, Powder Technology.

 Research Interest
Michael S Roberts

Michael S Roberts, PhD
Department of  Therapeutics & Pharmaceutical Science    
School of Pharmacy and Medical Sciences
University of South Australia, Australia

Biography :

Dr. Roberts is a NHMRC Senior Principal Research Fellow, Professor of Therapeutics & Pharmaceutical Science at the University of South Australia and Professor of Clinical Pharmacology & Therapeutics at The University of Queensland. He is also Director of the Therapeutics Research Centre based in the Translational Research Institute at the Princess Alexandra Hospital in Brisbane and in the Basil Hetzel Institute at The Queen Elizabeth Hospital in Adelaide.

 

 Biography
Research Interest :
 Research Interest
Audra Stinchcomb

Audra Stinchcomb, PhD
Department of Pharmaceutical Sciences
University of Maryland School of Pharmacy, USA

Biography :

Dr. Stinchcomb received her PhD in Pharmaceutics from University of Michigan. She completed her Post-Doctoral Fellowship (Biopharmaceutics) from University of California, San Francisco. In 2010 she was honoured with "Kentucky Entrepreneur Hall of Fame" & "Springboard Portfolio Company - All Things Life Sciences". In 2011 as AAPS Fellow.

 Biography
Research Interest :

Dr. Stinchcomb’s research is focused on transdermal prodrugs, microneedle-enhanced delivery, and translational research models for public-private partnerships.

 Research Interest
Sudip K Das

Sudip K Das, PhD
Department of Pharmaceutics
Butler University, USA

Biography :

Dr. Sudip K. Das is Professor of Pharmaceutics at the College of Pharmacy & Health Sciences, Butler University, Indianapolis, IN, where he also served as the chair of the Department of Pharmaceutical Sciences from 2004-09. After obtaining an undergraduate degree in pharmacy and MPharm and PhD in Pharmaceutics from India, Dr. Das pursued postgraduate training as a UNIDO scholar in pharmaceutical technology at the State University of Gent, Belgium. He continued postdoctoral training at The University of Queensland, Australia, following which he accepted a faculty position at Memorial University of Newfoundland, Canada. Before joining Butler, Dr. Das held faculty positions in pharmacy colleges at Nova Southeastern University and Idaho State University. Dr. Das has over twenty years of teaching experience in the professional pharmacy and graduate programs in the USA and Canada. He has supervised a number of postdoctoral, graduate and undergraduate research students, and was the key faculty responsible for the revitalization of the graduate program and research infrastructure in pharmaceutical sciences at Butler University Dr. Das has over 150 research publications, review articles, patents, proceedings, conference presentations, and book chapters, is a recipient of multiple awards/honors, and has secured extramural research funding from NIH, PDA, etc., and the pharmaceutical industry. Dr. Das has been an active member of AACP since 1994, where he became an AACP Leadership Fellow (2005), and served as the chair-elect, chair and immediate past chair of the Teachers of Pharmaceutics Section (2006-09). As the section chair, he strongly advocated the professional growth of the pharmaceutics faculty workforce, and the development of contemporary pharmaceutics curricula. From 2008-11, Dr. Das served as the founding chair and immediate past chair of the AACP Council of Sections, where he led the task of developing the mission and goals of the new council, and created various task forces supporting the missions of the AACP sections. He has also served on the AACP Board of Directors (2008-11), AACP Research & Graduate Affairs and the Bylaws and Policy Development Committees, along with various AACP Task Forces. Dr. Das is also an active member of AAPS (since 1991) and CRS (Controlled Release Society, since 1987). He has served on many committees of the PDD/PPB and BIOTEC sections of AAPS. Since 2004, he has served on several study sections for the NIH - Center for Scientific Review and continues to serve on the editorial boards of AJPE and Therapeutic Delivery.

 Biography
Research Interest :

His current research involves targeted delivery of siRNA and nano-composites for the treatment of cancer and neurodegenerative diseases.

 Research Interest
 Acceptance Letter
Jayachandra Ramapuram

Jayachandra Ramapuram, PhD
Harrison School of Pharmacy
Auburn University, USA

Biography :

Dr. Jayachandra Babu Ramapuram is an Associate Professor at the Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University. His research interests include formulation development of nanoparticle based formulations for topical and oral delivery, solubility improvement of insoluble drugs, percutaneous penetration enhancement techniques, transdermal drug delivery systems. He is currently major/co-major advisor to 5 Ph.D. students and has successfully graduated 5 students under his guidance. His laboratory is funded by few startup and mid-size pharmaceutical companies. He has authored and co-authored 50 research papers and 4 book chapters, and presented his research work in 60 poster and oral presentations in the several national and international conferences.

 Biography
Research Interest :

His research interests include formulation development of nanoparticle based formulations for topical and oral delivery, solubility improvement of insoluble drugs, percutaneous penetration enhancement techniques, transdermal drug delivery systems. He is currently major/co-major advisor to 5 Ph.D. students and has successfully graduated 5 students under his guidance.

 Research Interest
Neal Davies

Neal Davies, PhD
Dean and Professor
University of Manitoba, USA

Biography :

Dr. Davies received his undergraduate degree in Pharmacy from the University of Alberta in 1991. In 1996, he completed his Ph.D. in pharmaceutical sciences, specializing in pharmacokinetics, at the University of Alberta. From 1995 to 1998, he undertook postdoctoral training in pharmacology and toxicology at the University of Calgary. He then joined the University of Sydney as a lecturer in 1998. In 2002, he returned to North America to join the Washington State University’s (WSU) College of Pharmacy as an academic staff member, where he has held the positions of Director of the Pharmaceutical Sciences Graduate Program, as well as Director of Professional and Undergraduate Research and Director of Summer Undergraduate Research Fellowship program. Under his direction he has been involved in several administrative and operational initiatives including: strategic planning, faculty accreditation review processes; organizing the College retreat, establishment of a pharmaceutical sciences graduate program; and initiated the development of a comprehensive knowledge exam for the College’s PharmD program. Dr. Davies also championed the development of a College wide Pharmacy Research Day and has played key roles in faculty and graduate student recruitment and success. He has been active on numerous university-wide committees, including service as a member of WSU’s Faculty Senate and Chair of the Institutional Animal Care and Use Committee. Dr. Davies has strived to maintain the highest standard of teaching and research, and his achievements in both areas have been recognized through numerous awards and honours including several from the United States Pharmacopeia. He has taught at the undergraduate and graduate levels, and has an ongoing and significant commitment toward graduate supervision and training. He has been at the forefront of the use of technology in the classroom, has re-engineered curricular content and maintained a high standard in student mentoring.
Dr. Davies also maintains an active and highly collaborative externally-funded research program, focused on pharmacokinetics and drug delivery as well as basic and clinical pharmaceutical sciences which have attracted National Institutes of Health and Industry funds. He holds five patent applications and has disseminated his work broadly through numerous journal publications, book chapters, abstracts, and invited conference presentations.

 Biography
Research Interest :

Dr. Davies' research program in the Faculty of Pharmacy aims to investigate the factors that influence variability in drug response through an understanding of drug delivery (nanomedicine) and disposition (pharmacokinetics) as well as action to optimize the use of anti-oxidant and anti-cancer agents. The Davies laboratory explores factors affecting the dissolution, stability, release and safety and efficacy of anti-oxidant nutraceutical and anti-cancer drugs, the role of liver and renal metabolism in determining effects of drugs

 Research Interest
Vijaykumar B Sutariya

Vijaykumar B Sutariya, PhD
Department of Pharmaceutical Sciences
University of South Florida, USA

Biography :
 Biography
Research Interest :

Dr. Sutariya's research interest lies in Brain targeted delivery systems, thermo-reversible gel, nanoparticles, nanomedicine, liposomes etc.

 Research Interest
 Acceptance Letter
Prashanth Manda

Prashanth Manda, PhD
Department of Pharmaceutics
The University of Mississippi, USA

Biography :

Prashanth Manda is a Visiting Associate in the Division of Bioequivalence at USFDA. He was also an ORISE fellow in the Division of Product Quality Research (DPQR) at FDA. He obtained his Ph.D. in Pharmaceutics from The University of Mississippi. He published 8 peer-reviewed journal articles and over 20 abstracts. He is an inductee of phi kappa phi and Rho Chi Honorary Societies. He is also an active member of American Association of Pharmaceutical Sciences.

 Biography
Research Interest :

His research interest includes pre-formulation, formulation and kinetics of oral, nasal, sublingual, transungual, topical and transdermal drug delivery systems.

 Research Interest
Majella Lane

Majella Lane, PhD
UCL School of Pharmacy
Director, UCL Skin Research Group
University of London, UK

 

Biography :

Dr. Lane's areas of expertise include membrane transport, biophysical approaches towards the elucidation of drug-drug, drug-excipient and drug-membrane interactions, mechanisms of drug absorption, transdermal drug delivery, topical drug delivery, percutaneous absorption, peptide and protein formulation, ungual drug absorption, buccal drug absorption. Dr Lane's major research interests are in the development of optimal drug formulations for effective delivery of therapeutics, with special reference to skin, nail and to mucus membranes. Her research group uses a range of biophysical techniques to probe the mechanisms of skin and nail penetration and modulation.

 Biography
Research Interest :

Her specific areas of interest include:

  • Mechanisms of skin, nail and mucous membrane permeation.
  • Rational design of formulations for skin, nail and mucous membranes.
  • Action of penetration modulating agents (enhancers and retarders).
  • Dermatopharmacokinetics.
  • Confocal Raman Spectroscopy

 

 Research Interest
Muhammad J Habib

Muhammad J Habib, PhD
School of Pharmacy
Howard University, USA

Biography :

Dr. Habib received his PhD in Pharmaceutics from University of Alberta in 1987. He also obtained affiliations from American Association of Colleges of Pharmacy(AACP), American association of Pharmaceutical Sciences(AAPS), CRS, Rho Chi Pharmaceutical Society, American Pharmaceutical Association (APhA).

 Biography
Research Interest :
 Research Interest
Douglas F Boudinot

Douglas F Boudinot, PhD
Dean, Graduate School
Department of Pharmaceutics
Virginia Commonwealth University, USA

Biography :

Dr. Boudinot received his PhD. in Pharmaceutics from State University of New York in 1985. In 1979 - 1980 he worked as a Research Technician, Clinical Pharmacokinetics Laboratory at Millard Fillmore Hospital. In 1980 - 1985, He joined as Graduate Assistant, Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo. In 1985 - 1990 He moved to University of Georgia to join as Assistant Professor of Pharmaceutics, College of Pharmacy.  In 1986 - 2002 He was promoted to Faculty of Gerontology, University of Georgia Gerontology Center. From 2002 to present he was promoted to several posts such as Associate Professor, Head of Department, Associate Dean & Senior Associate Dean.
He was also a part of Faculty of Interdisciplinary Graduate Program in Toxicology, University of Georgia. Currently He is the  Dean of Graduate School, Virginia Commonwealth University.

 Biography
Research Interest :

Dr. Boudinot's research focuses on pharmacokinetics, biopharmaceutics, drug metabolism and pharmacodynamics in drug discovery and development. Research involves characterizing physicochemical properties of novel therapeutic agents, developing bioanalytical methodologies, conducting preclinical pharmacokinetic studies and developing pharmacokinetic models for interspecies scale up. Current work is focused on the pharmacokinetics of large molecular weight polyanionic compounds and characterization of physiological mechanisms involved in drug distribution and elimination.

 Research Interest
Kasturi Pawar

Kasturi Pawar,PhD
Department of Pharmaceutics
Auburn University, USA

Biography :

Dr. Kasturi Pawar is a pharmaceutics professional with Doctorate in Pharmaceutics and over 6 years of research experience in the areas of topical, transdermal oral formulation development and drug delivery, microneedles- and iontophoresis-assisted delivery, biomaterial synthesis, and analytical method development and validation using HPLC. Dr. Pawar is currently employed with Valeant Pharmaceuticals International as a Principal Research Scientist in Formulation development department. Prior to Valeant Pharmaceuticals International, Dr. Pawar has also held Lead Formulation Scientist positions in her previous jobs at Tioga Research Inc. and G&W Laboratories. She has earned her PhD from Auburn University, AL in 2013, and her Masters and Bachelors from India in 2007 and 2005, respectively. Prior to coming to USA, she was working as a Research Scientist with Sandoz Pvt. Ltd in India. Dr. Pawar has extensive experience working with challenging formulations and providing innovative ideas to troubleshoot the challenges. She has worked in collaboration with groups across the country, and authored and co-authored 6 research papers and 2 review papers, and presented her research work in 13 poster and oral presentations in the several national and international conferences. She has won several awards and honors in her career. She is currently serving as an active reviewer at the Annual National Meetings of American Association of Pharmaceutical Scientists. She is also a peer reviewer for Journal of Controlled Release, International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, Current Drug Delivery, Dove Medical Press Articles and SciTechnol articles. She serves as an editorial board member for two journals, Journal of Innovations in Applied Pharmaceutical Science and Journal of Innovations in Pharmaceuticals and Biological Sciences.

 Biography
Research Interest :

Kasturi Pawar research interests are topical/transdermal formulation development and delivery using active permeation techniques, solubility improvement of insoluble drugs, percutaneous penetration enhancement techniques, Oral solid formulation development and delivery, biomaterial synthesis, nanoparticle drug delivery and tissue engineering.

 Research Interest
Bivash Mandal

Bivash Mandal, PhD
Sr. Research Specialist
The University of Tennessee Health Science Center, USA

Biography :

Dr. Bivash Mandal is currently working as a Sr. Research Specialist at Plough Center for Sterile Drug Delivery Systems at the University of Tennessee Health Science Center, Memphis, TN, USA. He obtained Bachelor of Pharmacy degree and Masters of Pharmacy degree (major in Pharmaceutics) from Jadavpur University, India. He pursued MS degree in Pharmaceutical Sciences with Industrial Pharmacy major from University of Toledo, Ohio, USA. He completed his Ph.D. degree in Pharmaceutics from the University of Tennessee Health Science Center, Memphis, TN, USA. Prior to joining the MS program, he worked as a scientist in the formulation R & D department at Dr. Reddy’s Laboratories Ltd., India. He has authored in many scientific peer-reviewed articles, patent application and conference presentations. He serves as the editorial board members, reviewers in many pharmaceutical science journals and received prestigious AAPS graduate research award.

 Biography
Research Interest :

Advanced and novel drug delivery systems, nanomedicines including liposomes, antibody conjugated nanoparticles, polymeric nanoparticles, injectables and oral solid drug product development, pre-formulation, formulation, solubilization techniques, lyophilization, parenteral manufacturing, analytical method development and validation.

 Research Interest
Varun Khurana

Varun Khurana, PhD
Insys Therapeutics, Inc.,
USA

Biography :

Dr. Varun Khurana obtained his Bachelors in Pharmacy from Guru Gobind Singh Indraprastha University, Delhi,, India. Dr. Khurana graduated with a Ph.D. in Pharmaceutical Sciences and Chemistry from reputed University of Missouri Kansas City, Kansas City, MO, USA. Currently, he is working as Formulations Scientist at Insys Therapeutics, Inc., USA, a specialty pharmaceutical company that develops and commercializes innovative supportive care products. Dr. Khurana’s research experience encompasses both industry and academia. Dr. Khurana worked on National Institutes of Health (NIH) funded research projects. Dr. Khurana’s research was focused on understanding the role of drug transporters (influx as well as efflux) in disposition of various anti-cancer drugs. He not only studied the alteration of drug pharmacokinetics via drug transporters in liver but also how the modulation affects brain as well plasma pharmacokinetics of anti-cancer drugs. Furthermore, his research work was focused on ocular drug delivery through nanoparticles. His research has been published in several peer-reviewed journals and books in the field of pharmaceutical sciences. Dr. Khurana’s current research at Insys Therapeutics is focused on development of oral solutions and sublingual sprays for new product development.

 Biography
Research Interest :

Novel Drug Delivery Systems, Solubility and Bioavailability Enhancement, Targeted Drug Delivery, Cancer Therapy, Targeted Delivery, Gene Therapy, Nanotechnology, Novel Drug Delivery Systems, Formulation Development (Oral solids, Liquid andParenterals), Controlled or Modified Release.

 Research Interest
Yihua Bruce Yu

Yihua Bruce Yu, PhD
Department of Pharmaceutical sciences and Bioengineering
University of Maryland, USA

Biography :

Dr. Yihua Bruce Yu is an Associate professor of Pharmaceutical sciences and Bioengineering at the University of Maryland. Prior to joining the University of Maryland, he was assistant professor at the University of Utah. He received his Ph.D. in molecular biophysics from the Johns Hopkins University and conducted postdoctoral work at the University of Alberta in peptide chemistry. His current research interest includes biomaterials engineering and imaging agent development. He received the 2004 Kimmel Scholars Award for his work on imaging agent development and the 2005 Presidential Early Career Awards for Scientists and Engineers for his work on biomaterials.

 Biography
Research Interest :

Dr. Bruce Yu's research has two main thrusts: biomaterials engineering and imaging technologies. In the biomaterials area, our current focus is the link between molecular chirality and material mechanical properties, exploiting chirality to create biomaterials with novel mechanical properties for cell growth and differentiation. In the imaging area, we develop imaging agents for multi-color F-19 MRI. He is also working a MRI technology to evaluate the mechanical properties of soft materials and biological tissues.

 Research Interest
Richard A Gemeinhart

Richard A Gemeinhart, PhD
Director of Graduate Education
College of Pharmacy
University of Illinois, USA

Biography :

Dr. Richard A. Gemeinhart received his PhD in Pharmaceutics from Purdue University. From 1995 to present He is a memeber Rho Chi Pharmacy Honor Society. In 2006 he was invited to The Society For Biomaterials Young Investigator. In 2006-2007 he was awarded with Hans W. Vahlteich Scholar.

 Biography
Research Interest :

Dr. Gemeinhart's Research interest lies in Biomaterials for Tissue Regeneration, Micro/Nanostructures, Drug Conjugates for Cancer Therapy & many others.

 Research Interest
Tahseen Mirza

Tahseen Mirza, PhD
Deputy Office Director
Food and Drug Administration, USA

Biography :

Dr. Tahseen Mirza is an accomplished scientist and leader with over twenty years of industrial and regulatory experience in the areas of generic and branded pharmaceutical development. He holds a Ph.D. in Pharmaceutical Sciences from University of Cincinnati.
In his current job, Dr. Mirza is Division Director of the FDA Office of Manufacturing and Product Quality’s (OMPQ) Division of Policy, Collaboration and Data Operations (DPCDO). Prior to joining OMPQ, Dr. Mirza was the Deputy Director of the Division of Product Quality Research (DPQR), within The Office of Pharmaceutical Science’s (OPS) Office of Testing and Research (OTR). Before joining the FDA, he was a Director in the Technical R&D department of Novartis Pharmaceutical Corp, East Hanover, NJ. During his career, Tahseen has led groups of chemists and Ph.D. level scientists in various R&D and QC/QA departments and is well versed in both early and late phase product development. He has enabled the transfer of manufacturing processes and analytical methods globally between R & D and manufacturing and contract manufacturers. He has also worked in various capacities for Sanofi Aventis, Merial/Merck and the United States Pharmacopeia. At the USP he served as a USP Liaison between FDA, industry and three USP Expert Committees; Dissolution and Bioavailability (Biopharmaceutics), Pharmaceutical Dosage Forms and Biostatistics he coordinated the efforts towards establishing sound analytical methods and compendial monograph standards. He has lectured and trained industry and FDA scientists in Manufacturing Science, Biopharmaceutics and Dissolution. He has moderated national and international conferences and workshops on variety of topics such as drug release, dissolution, QbD and PAT. Dr. Mirza has lectured and trained industry and FDA scientists in Manufacturing Science, Biopharmaceutics and Dissolution. He has co-authored more than 30 research articles. He has moderated national and international conferences and workshops on variety of topics such as drug release, dissolution, QbD and PAT. Dr. Mirza is the founding Chairman of the AAPS focus group, In Vitro Release and Dissolution.

 Biography
Research Interest :

Dr. Tahseen's interest lies in Regulatory research Projects.

 Research Interest
Moses Oyewumi

Moses Oyewumi, PhD
College of Pharmacy
Northeast Ohio Medical University, USA

Biography :

Dr. Moses Oyewumi is an Assistant Professor in the Department of Pharmaceutical Sciences at the Northeast Ohio Medical University College of Pharmacy. Dr. Oyewumi earned his Ph.D. from the University of Kentucky in 2003 and completed post-doctoral training at the University of Kentucky and at the University of Iowa in 2005. prior to joining NEOMED, Dr. Oyewumi was a Scientist, Pharmaceutics R&D for four years in a pharmaceutical industry. He is having many patents in his name.

 Biography
Research Interest :
  • Design, development and application of novel nanoparticulate/microparticulate delivery systems.
  • Assessment of novel drug delivery systems using in-vitro and in-vivo models.
  • Targeted drug delivery systems in cancer, neuroprotection and neurodegeneration.
  • Nasal drug delivery systems in CNS diseases.
  • Oral delivery of macromolecules.
 Research Interest
Peter York

Peter York, PhD
University of Bradford, UK
Chairman and A Co-Founder
Crystec Pharma Ltd.
 

Biography :

Professor York has a background and broad experience in the areas of pharmaceutical material science and processing, and the design and evaluation of drug delivery systems. Over recent years his research focus has been in crystal engineering and particle design of drugs using supercritical fluid technologies, in silico tools for knowledge engineering, and the modernisation of Chinese traditional medicine. Dr York has published widely in these fields and holds numerous patents and has consulted widely. He has been a member of various pharmacopoeia and regulatory committees in the UK and Europe and currently acts as an expert advisor to the MHRA and WHO. Dr York has also been a co-founder of several start-up hi-tech university companies and in 2008 Professor York was honoured as a Visiting Professor at the Shanghai Institute of Materia Medica.

 Biography
Research Interest :

His research activities involve pharmaceutical material science, coupled to aspects of chemical engineering and processing, with particular focus on molecular modelling and solid-state structure, particle formation including novel processes using supercritical fluid technology, and drug delivery design.

 Research Interest
Graham Buckton

Graham Buckton, PhD
Emeritus Professor of Pharmaceutics
UCL School of Pharmacy, UK
 

Biography :

Dr. Graham graduated with BPharm from Chelsea College, PhD from King’s College London and Doctor of Science in 1997, for “Materials characterisation of importance to drug delivery”. In 2012 he passed the IoD Certificate and Diploma in Company Direction. Professor Buckton is a fellow of the Royal Pharmaceutical Society, Royal Society of Chemistry, AAPS and APSGB, he is a Freeman of the City of London. He joined the staff of King’s College London as lecturer in pharmacy in 1984. In 1989 he moved to the School of Pharmacy, University of London where he progressed through the positions of Lecturer, Senior Lecturer, Reader and Professor and was the Head of Department and Professor of Pharmaceutics. Until Sept 2012 he was Chief Executive Officer of Pharmaterials Ltd which is the contract research company that he founded in 2000. He served a 10 year term as Editor of the International Journal of Pharmaceutics and has recently served, on the editorial boards of Pharmaceutical Research, The AAPS Journal and the steering committee for the Excipients Handbook. Was the first Chairman of the Academy of Pharmaceutical Sciences of GB and a past Chairman of the Pharmaceutical Sciences Group of the Royal Pharmaceutical Society of Great Britain. Was past Chairman of the Chemistry, Pharmacy and Standards sub-committee of the Committee on Safety of Medicines and a member of the CSM, is a member of the CPS TAG of the Commission on Human Medicines. Was Science Chairman of the British Pharmaceutical Conference 2003. Was a British Pharmacopoeia Commissioner and contributes to Ph Eur, USP and EMEA working parties.

 Biography
Research Interest :

His research relates to the study of physical properties of materials in relation to drug delivery. This involves extensive study of the amorphous state, it structure, changes with time, and impact on materials processing for inhalation delivery. Research also relates to poorly soluble drug delivery systems. Tools used include thermal analysis and surface analysis. I am the UCL School of Pharmacy Director for the EPSRC Centre for Doctoral Training in Targeted Therapeutics with the University of Nottingham and AZ, Alliance Boots, GSK, Pfizer and Quotient.

 Research Interest
Neil Foster

Neil Foster , PhD
School of Chemical Engineering
The University of New South Wales, Australia

Biography :

Dr. Foster is the Director of Supercritical Fluids Research & Dense Gas Technologies Programme and also Director of Process Intensification & Sustainability Programme. In 1999, he was awarded with "The John Brodie Medal". In 2006 he obtained "Royal Australian Chemical Institute Applied Research Award" & in 2009 "The RACI R K Murphy Medal". At 2010-2012 he was awarded with People's Republic of China "Qian Ren 1000 Talents" Programme Professorship.

 Biography
Research Interest :
 Research Interest
Vinayagam Kannan

Vinayagam Kannan, PhD
Senior Formulation Development Scientist
Par Sterile Products, LLC
Rochester, USA

Biography :

Dr. Vinayagam Kannan is a Senior Scientist, Formulation R&D at Par Sterile Products, LLC. He has a Ph.D. in Pharmaceutical Sciences from The University of Tennessee Health Science Center (UTHSC). He obtained master’s degree in Pharmaceutics from National Institute of Pharmaceutical Education and Research (NIPER), India and bachelor’s degree in Pharmacy from The Tamil Nadu Dr.MGR Medical University, India. He has an excellent academic record with several awards and fellowships. He was inducted into The Rho Chi Honor Society in the year 2009 for his academic excellence.

 Biography
Research Interest :

Injectable and ophthalmic drug product development, pre-formulation, solubilization techniques, lyophilization, targeted drug delivery, nanoparticulate systems including liposomes, design of experiments (DOE), Quality by Design (QbD), extractables/leachables, and salt selection/screening.

 Research Interest
Arik Dahan

Arik Dahan, PhD
Department of Clinical Pharmacology
Ben-Gurion University of the Negev, Israel

Biography :

Arik Dahan is an Assistant Professor in Ben-Gurion University of the Negev. He did his postdoctoral research from University of Michigan. He received his PhD from The Hebrew University of Jerusalem in the year 2007. He has published more than 35 research manuscripts, and has more than 15 lectures and poster presentations.

 Biography
Research Interest :

His research focuses on integrating up-to-date molecular and cellular mechanistic investigations of drug disposition in the context of the human body, in order to enable successful drug delivery and therapy. In implementing this molecular biopharmaceutical approach to ADME research, he is seeking to enable mechanistic-based successful solutions to drug delivery, especially (but not only) oral, in challenging scenarios e.g. low-solubility, low-permeability, efflux transport, extensive metabolism, poor site targeting, various pathophysiological conditions, and pediatrics patient care.

 Research Interest
Ijeoma F. Uchegbu

Ijeoma F Uchegbu, PhD
Co Founder of nanomerics
Professor
UCL School of Pharmacy, UK

Biography :

jeoma Uchegbu is Professor of Pharmaceutical Nanoscience within the UCL School of Pharmacy. She obtained her PhD from the School of Pharmacy in 1994 and was appointed to a lectureship in Drug Delivery in 1997 within the University of Strathclyde. She became a senior lecturer in 2000 and a Professor of Drug Delivery in 2002. She then joined the School of Pharmacy as a Professor of Pharmaceutical Nanoscience in 2006 and joined UCL in 2012. In 2010 Ijeoma became cofounder Chief Scientific Officer of Nanomerics Ltd, a specialty pharmaceutical company and spin out from UCL. Ijeoma has won numerous prizes for her work including the UK's Department of Business Innovation and Skills' Women of Outstanding Achievement Award in 2007 and the Royal Pharmaceutical Society's Pharmaceutical Scientist of the Year Award in 2012.

 Biography
Research Interest :

Her research is based on fundamental physical chemistry principles to fabricate functional pharmaceutical nanoparticles - nanomedicines.

 Research Interest
SM Moghimi

SM Moghimi, Ph.D
Department of Nanomedicine and Biopharmacy
Department of Pharmaceutics & Analytical Chemistry
University of Copenhagen , Denmark

Biography :

Dr. Moghimi earned his Bachelor degree in Biochemistry with Honors from the University of Manchester (UK), and his Doctorate in Biochemistry/Immunobiology from Charing Cross and Westminster Medical School, Imperial College, London. Following postdoctoral training and a University Fellowship at the School of Pharmaceutical Sciences at Nottingham University (UK), he moved to the University of Brighton as a senior lecturer in Biopharmacy and Molecular Therapy. In 2008, he accepted the chair of Nanomedicine at the University of Copenhagen (Denmark), where he currently heads the Nanomedicine Research Group at the School of Pharmacy, Faculty of Health and Medical Sciences. In 2009, he founded the Centre for Pharmaceutical Nanotechnology and Nanotoxicology (CPNN) at the NanoScience Centre of Copenhagen University through a multi-million dollar award by the Strategic Research Council of Denmark, where he acts in the capacity of centre director. Dr. Moghimi is also the honorary professor of Nanomedicine at the Multidisciplinary Research Center, Shantou University (China) and an elected fellow of the Institute of Nanotechnology in the UK. Since 2009, Dr. Moghimi has secured over US$13 million in competitive research funds in basic and applied nanomedicine research as the principal investigator and is currently a partner in two large-scale competitive European Commission FP-7 programs in translational nanomedicine/drug delivery, addressing Alzheimer’s disease and atherosclerosis with secured budgets of US$ 14.5 million and US$ 11 million, respectively. Dr. Moghimi serves as the associate editor of Nanomedicine: Nanotechnology, Biology and Medicine (Elsevier) and the Journal of Biomedical Nanotechnology, and sits on the editorial/advisory board of over 15 peer-reviewed international journals, including Advanced Drug Delivery Reviews, Nanomedicine-UK (Future Medicine), and Molecular and Cellular Therapies (BioMed Central). Dr. Moghimi has been a practicing consultant to numerous pharmaceutical, biotechnology, health and food industry companies as well as investment banks, management consultancy firms, and other entrepreneurial enterprises globally for over two decades. He is also a regularly invited assessor and expert evaluator in nanomedicine and pharmaceutical science research centers/research projects for governmental bodies, research councils, and private organizations worldwide (> 50 establishments in 20 countries). As a frequent keynote and guest speaker at many international conferences and organizations, as well as being regular conference chair and organizer, Dr. Moghimi has given over 300 invited speeches and lectures. He has published over 170 peer-reviewed articles in prestigious international journals and book chapters, and is the inventor of many patents.

 Biography
Research Interest :

Dr. Moghimi’s research activities are focused on pharmaceutical nanoscience, nanotechnology in iMedicine, nanotoxicology and fundamental/translational nanomedicine in relation to cancer, neurodegenerative diseases, cardiovascular diseases, and immunological disorders. He has pioneered research in the design and surface engineering of nanoparticles and functional nanosystems for parenteral site-specific targeting/drug delivery and imaging modalities (e.g., splenotropic entities, lymphotropic agents, ‘phagocyte-resistant’ nanoparticles, cancer nanomedicine, cerebral endothelial-specific nanoparticle-fiber networks) as well as the molecular basis of nanomaterial immune toxicity, polymer cytotoxicity, and preventive measures.

 Research Interest
Yilmaz Capan

Yilmaz Capan, PhD
Department of Pharmaceutical Technology
Hacettepe University, Turkey

Biography :

Yilmaz Capan is Professor of Pharmaceutical Technology and Head of the Pharmaceutical Technology Department at Hacettepe University Faculty of Pharmacy, Ankara, Turkey. Professor Capan received his Ph.D. from the University of Lille II, France in 1978. He has been a Visiting Scientist at University of Lille II, Faculty of Pharmacy and at University Paris-Sud, Faculty of Pharmacy, Paris-France and was a Visiting Professor at Louis Pasteur University, Faculty of Pharmacy, Strasbourg-France and at University of Kentucky College of Pharmacy. He has thirty-five published refereed-journal articles, twenty published non-refereed journal articles and three published books. Professor Capan holds memberships in the American Association of Pharmaceutical Scientists, Association of Pharmaceutical Sciences of Ankara, Turkish Pharmacists' Association and Pharmacist's Chamber of Ankara.

 Biography
Research Interest :
 Research Interest
 
izmit escort sex geschichten escort bayan porno sikis adult porno pornolar
anakara escort
test